FGF-1

[Darrin Class]

I’m watching the Zoom update on FGF-1 trials in the British VI and cannot help but feel like I’m watching a diet pill/device infomercial.

it didn’t help to receive an email that seemed to promote medical tourism.

[Mary Beth Skylis]

I, personally, find it odd that we advertise medications and that type of thing, too. It always feels like it’s about the money.

[Chris Guss]

I have also been on the Zhittya zoom calls and also have mixed emotions. CEO Dan’s diatribes about the FDA, how much money they have already invested, and even announcing that he dosed himself with FGF-1 appear to me as unprofessional and discrediting to the overall cause.

On the other hand, I find the fMRI images of vascular growth intriguing and the hypothesis that alpha synuclean accumulation is due to vascular damage worthy of investigation.

I would like to see pre and post imaging of vascular changes in future volunteer subjects as well as continued follow-up with the 2 subjects presented on the last call.

I wish everyone involved only the best and am grateful for their efforts. I look forward to future updates.

[Author]

Posts